These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8180744)

  • 1. The role of extraplatelet thromboxane A2 in unstable angina investigated with a dual thromboxane A2 inhibitor: importance of activated monocytes.
    Neri Serneri GG; Gensini GF; Poggesi L; Modesti PA; Rostagno C; Boddi M; Gori AM; Martini F; Ieri A; Margheri M
    Coron Artery Dis; 1994 Feb; 5(2):137-45. PubMed ID: 8180744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiological role of thromboxane A2 and pharmacological approaches to its inhibition.
    Patscheke H; Hornberger W; Zehender H
    Z Kardiol; 1990; 79 Suppl 3():151-4. PubMed ID: 2099038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential suppression of thromboxane biosynthesis by indobufen and aspirin in patients with unstable angina.
    Cipollone F; Patrignani P; Greco A; Panara MR; Padovano R; Cuccurullo F; Patrono C; Rebuzzi AG; Liuzzo G; Quaranta G; Maseri A
    Circulation; 1997 Aug; 96(4):1109-16. PubMed ID: 9286937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insights into the role of thromboxane A2 and serotonin in the pathogenesis of unstable angina.
    Machado AP; Saavedra JA; Ribeiro C
    Rev Port Cardiol; 1994 Dec; 13(12):935-46, 893. PubMed ID: 7873224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal cardiocoronary thromboxane A2 production in patients with unstable angina.
    Neri Serneri GG; Gensini GF; Abbate R; Prisco D; Rogasi PG; Laureano R; Casolo GC; Fantini F; Di Donato M; Dabizzi RP
    Am Heart J; 1985 Apr; 109(4):732-8. PubMed ID: 3984828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased number of thromboxane A2-prostaglandin H2 platelet receptors in active unstable angina and causative role of enhanced thrombin formation.
    Modesti PA; Colella A; Cecioni I; Costoli A; Biagini D; Migliorini A; Neri Serneri GG
    Am Heart J; 1995 May; 129(5):873-9. PubMed ID: 7732975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Picotamide, a combined inhibitor of thromboxane A2 synthase and receptor, reduces 2-year mortality in diabetics with peripheral arterial disease: the DAVID study.
    Neri Serneri GG; Coccheri S; Marubini E; Violi F;
    Eur Heart J; 2004 Oct; 25(20):1845-52. PubMed ID: 15474700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition by picotamide of thromboxane production in vitro and ex vivo.
    Violi F; Ghiselli A; Iuliano L; Praticò D; Alessandri C; Balsano F
    Eur J Clin Pharmacol; 1988; 33(6):599-602. PubMed ID: 3366163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of low-dose aspirin and coronary vasodilators in acute unstable angina.
    Vejar M; Hackett D; Brunelli C; Spallarossa P; Ianetti M; Galassi AR; Lipkin D; Caponnetto S; Patrono C; Maseri A
    Circulation; 1990 Jan; 81(1 Suppl):I4-11; discussion I22-3. PubMed ID: 2403867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of integrelin, a platelet glycoprotein IIb/IIIa receptor antagonist, in unstable angina. A randomized multicenter trial.
    Schulman SP; Goldschmidt-Clermont PJ; Topol EJ; Califf RM; Navetta FI; Willerson JT; Chandra NC; Guerci AD; Ferguson JJ; Harrington RA; Lincoff AM; Yakubov SJ; Bray PF; Bahr RD; Wolfe CL; Yock PG; Anderson HV; Nygaard TW; Mason SJ; Effron MB; Fatterpacker A; Raskin S; Smith J; Brashears L; Gottdiener P; du Mee C; Kitt MM; Gerstenblith G
    Circulation; 1996 Nov; 94(9):2083-9. PubMed ID: 8901655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oxidant stress and aspirin-insensitive thromboxane biosynthesis in severe unstable angina.
    Cipollone F; Ciabattoni G; Patrignani P; Pasquale M; Di Gregorio D; Bucciarelli T; Davì G; Cuccurullo F; Patrono C
    Circulation; 2000 Aug; 102(9):1007-13. PubMed ID: 10961965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Binding kinetics and antiplatelet activities of picotamide, a thromboxane A2 receptor antagonist.
    Modesti PA; Cecioni I; Colella A; Costoli A; Paniccia R; Neri Serneri GG
    Br J Pharmacol; 1994 May; 112(1):81-6. PubMed ID: 8032666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboxane A2 in vasotonic angina pectoris: evidence from direct measurements and inhibitor trials.
    Robertson RM; Robertson D; Roberts LJ; Maas RL; FitzGerald GA; Friesinger GC; Oates JA
    N Engl J Med; 1981 Apr; 304(17):998-1003. PubMed ID: 7010173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of picotamide on the calcium mobilization and phospholipase C activation in human platelets.
    Pulcinelli FM; Pignatelli P; Riondino S; Parisi S; Castiglioni C; Gazzaniga PP
    Thromb Res; 1994 Jun; 74(5):453-61. PubMed ID: 8085246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antivasoconstrictor and antiaggregatory activities of picotamide unrelated to thromboxane A2 antagonism.
    Vezza R; Spina D; Tallarida RJ; Nathan M; Page CP; Gresele P
    Thromb Haemost; 1997 Nov; 78(5):1385-91. PubMed ID: 9408024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet activation in unstable coronary disease.
    Fitzgerald DJ; Roy L; Catella F; FitzGerald GA
    N Engl J Med; 1986 Oct; 315(16):983-9. PubMed ID: 3531859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of picotamide on human platelet aggregation, the release reaction and thromboxane B2 production.
    Cattaneo M; Tenconi PM; Lecchi A; Mannucci PM
    Thromb Res; 1991 Jun; 62(6):717-24. PubMed ID: 1926062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered intraplatelet arachidonic acid metabolism during the acute state of unstable angina.
    Neri Serneri GG; Abbate R; Panetta A; Pinto S; Favilla S; Prisco D; Gensini GF
    Thromb Res; 1987 Apr; 46(2):303-16. PubMed ID: 3111003
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of N,N'-bis(3-picolyl)-4-methoxy-isophtalamide (picotamide) as a dual thromboxane synthase inhibitor/thromboxane A2 receptor antagonist in human platelets.
    Gresele P; Deckmyn H; Arnout J; Nenci GG; Vermylen J
    Thromb Haemost; 1989 Jun; 61(3):479-84. PubMed ID: 2552606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The in vivo antiplatelet effects of thromboxane A2 synthase inhibitors are potentiated by simultaneous thromboxane A2/prostaglandin H2 receptor blockade.
    Golino P; Ambrosio G; Gresele P; Pascucci I; Ragni M; Russolillo E; Leproux GB; Chiariello M
    J Pharmacol Exp Ther; 1993 Aug; 266(2):511-7. PubMed ID: 8355187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.